News

Sai Parenterals has received a purchase order valued at USD 11 million at an exchange rate of Rs 95 (Rs 104.50 crore) from PILL CORP, Bulacan, Philippines. The contract is for supply of anti TB products for the Philippines market on exclusivity basis for a period of 10 years.

Sai Parenteral`s will hold a meeting of the Board of Directors of the Company on 23 May 2026.

Sai Parenterals will hold a meeting of the Board of Directors of the Company on 20 April 2026.

Sai Parenteral`s will hold a meeting of the Board of Directors of the Company on 20 April 2026.

The equity shares of Sai Parenterals (Scrip Code: 544742) are listed effective 02 April 2026 and admitted to dealings on the exchange in the list of ``B`` group securities. At 09:09 IST, the pre-open indicative price of the stock was at a premium of 1.79% to the IPO price of Rs 392.